The Chinese government will begin dispersing funds this October for two major research programs that were initially announced two years ago. Although a final figure has yet to be released, observers estimate that $880 million will be allocated for drug discovery research and $440 million will be available for infectious disease research. The projects will […]
According to La Merie Business Intelligence, the top five Japanese pharmaceutical companies in terms of 2007 total sales were: Takeda Pharmaceutical ($12.5 billion), Astellas Pharma ($9.0 billion), Daiichi Sankyo ($8.2 billion), Eisai ($6.8 billion) and Otsuka Pharmaceutical ($3.8 billion). The only firms among the top 20 with sales declines last year were Daiichi Sankyo (-5.3%), […]
An innovation review delivered to the Australian government in August proposes changes in order to boost the country’s R&D spending from 0.55% of GDP to 0.75% of GDP by 2010. Among the proposals are the replacement of the current R&D tax credit, which offers companies an AUD 7.5 cents tax credit per dollar spent on […]
Despite rising costs, India will continue to be a popular site for offshore R&D, according to consulting firm Zinnov, which conducted interviews with 120 foreign R&D centers in India. The offshore R&D industry is worth $9.35 billion, is growing 23% annually and is forecasted to be $21.4 billion by 2012. Multinational corporations are fueling the […]
New nutrition labeling laws for Hong Kong will take effect on July 1, 2010. The laws require that prepackaged food sold in the territory be labeled for energy, protein, carbohydrates, fat, saturated fat, trans fast, sodium and sugars. Hong Kong will become the only market with such requirements, which are more strict than Codex proposals. […]
Total R&D spending in Israel increased 7.2% in 2007 in constant prices to NIS 31.5 billion ($8.7 billion), or 4.7% of GDP. R&D spending by the business sector represented 79% of all R&D expenditures last year and rose 8.9%. Government R&D spending grew 4.2% and accounted for 5% of spending, while R&D expenditures by nonprofit […]
Korea’s Ministry of Education, Science and Technology has announced the “577 Initiative,” under which the government plans to increase R&D funding to 5% of GDP within five years to make the country one of the seven science and technology leaders worldwide. Seven industries will be targeted, including semiconductors, automobiles and machinery. In addition, health care […]
The Russian government plans to spend $2.7 billion by 2015 to revitalize the country’s chemicals industry. The Industry and Trade Ministry program will produce 200 projects in the chemicals sector and 10,000 new jobs. Closely linked to the 2007–2015 State Armament Program, the funding will primarily go toward the development and production of carbon-fiber composites, […]
The outsourcing of drug development and manufacturing to India and China by US companies is escalating because of the high rate of patent expirations. The weak US dollar is also causing foreign investors to pull their money out of India and, in turn, weaken the rupee. India’s larger pharmaceutical companies are reaping the inadvertent benefits […]
According to a survey of 255 companies conducted by Japanese financial newspaper Nikkei Shimbun and published in July, R&D investment by Japan’s private sector totaled JPY 12.5 trillion ($113.16 billion), a 6.9% increase. Of the companies surveyed, 32.9% plan to increase R&D spending by more than 10% within the next five years. Fifty-five percent of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
